FDA Relying On Pedigree Info To Authorize Use Of Imported Flu Vaccine
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is relying on confirmed lot numbers and pedigree information to authorize the use of Sanofi-Aventis' Fluzone purchased directly from European distributors by state and local governments